Recursion (RXRX) 2025 Earnings: Deep Dive Into Strategy
As biotech investors digest Recursion's latest quarterly results, this Deep Dive breaks down what recursion (rxrx) 20...
Index funds generally provide more control over allocations than target date funds, which automate drift. This intro explains what that means in practice.
28,480 articlesAs biotech investors digest Recursion's latest quarterly results, this Deep Dive breaks down what recursion (rxrx) 20...
Marvell Technology shares surprised investors with a notable intraday uptick amid improving sentiment for semiconduct...
Netflix just posted a record quarterly revenue, but the forecast for the next quarter came in softer than expected. H...
A downgrade and AI chip headlines pushed Broadcom stock lower today. Here’s what happened, what it could mean, and pr...
Two high-growth names face near-term headwinds. This guide explains why patient investors could benefit from the pull...
Vericel faces a pivotal 2026 earnings season. This guide breaks down the drivers behind the numbers, what to watch in...
Market pullbacks can feel daunting, but they’re prime opportunities for long-term gains. This guide reveals how to id...
When Paris Hilton joins the hunt for a notorious deepfake site, it isn’t just celebrity news—it’s a case study in dig...
Qualcomm is trading at a discount to peers while building a strong AI silicon footprint. With a June Investor Day and...
PepsiCo’s chief people officer says the company wins by hiring people who hustle, stay curious, and adapt quickly in ...
A renowned artist and philanthropist reveals a different dream: winemaking. This article turns that tale into practic...
Inside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...